Hochschulschrift
Evaluation and targeting of IL-6 signalling in cholangiocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
135 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Eberhard Karls Universität Tübingen, Dissertation, 2019
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (when)
-
2020
- Creator
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:48 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Time of origin
- 2020
Other Objects (12)
Identification and molecular targeting of new signalling pathways in melanoma
Targeting proinflammatory signalling pathways in primary sclerosing cholangitis
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
Targeting developmental signalling pathways in experimental gliomas by overexpression of NUMB
Targeting adiponectin signalling pathway as a new anticancer treatment for cholangiocarcinoma
Targeting the tumour microenvironment : from thyroid hormone signalling to gene therapy
Targeting JAK/STAT signalling for sensitization of colorectal cancer cells to chemoradiotherapy
Robustness and information transfer within IL-6-induced JAK/STAT signalling
An Evaluation of Inflation Targeting in Germany and the UK
Targeting the NO-cGMP-PKG signalling pathway protects the heart against ischemia-reperfusion injury
Signalling, information and consumer fraud
Needs and Targeting
Identification and molecular targeting of new signalling pathways in melanoma
Targeting proinflammatory signalling pathways in primary sclerosing cholangitis
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
Targeting developmental signalling pathways in experimental gliomas by overexpression of NUMB
Targeting adiponectin signalling pathway as a new anticancer treatment for cholangiocarcinoma
Targeting the tumour microenvironment : from thyroid hormone signalling to gene therapy
Targeting JAK/STAT signalling for sensitization of colorectal cancer cells to chemoradiotherapy
Robustness and information transfer within IL-6-induced JAK/STAT signalling
An Evaluation of Inflation Targeting in Germany and the UK
Targeting the NO-cGMP-PKG signalling pathway protects the heart against ischemia-reperfusion injury
Signalling, information and consumer fraud
Needs and Targeting
Identification and molecular targeting of new signalling pathways in melanoma
Targeting proinflammatory signalling pathways in primary sclerosing cholangitis
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
Targeting developmental signalling pathways in experimental gliomas by overexpression of NUMB
Targeting adiponectin signalling pathway as a new anticancer treatment for cholangiocarcinoma
Targeting the tumour microenvironment : from thyroid hormone signalling to gene therapy
Targeting JAK/STAT signalling for sensitization of colorectal cancer cells to chemoradiotherapy
Robustness and information transfer within IL-6-induced JAK/STAT signalling
An Evaluation of Inflation Targeting in Germany and the UK
Targeting the NO-cGMP-PKG signalling pathway protects the heart against ischemia-reperfusion injury
Signalling, information and consumer fraud